Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets
Final approval for diabetes and heart-failure drug opens access to a $10.5 billion US market opportunity, with shared exclusivity benefits.
Health of the Nation 2026, based on over 3 million assessments, finds rising diabetes, obesity, and hidden cardiac risks in under-30s and working professionals
Former Interim CEO takes charge to drive strategic growth, strengthen clinical excellence, and advance patient-centric oncology innovation
Veteran HR leader comes with over two decades of experience to spearhead talent strategy, leadership development, and culture transformation
Safety was equally impressive. ENV-294 was well tolerated
He brings extensive cross-functional expertise built through leadership roles
With more than two decades of experience, he brings deep expertise in sales, marketing, business transformation, and strategic leadership
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
Board approves five-year appointment, subject to shareholder nod through postal ballot
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
